Filing Flows

Filing Flows › 8-K events › OSR Health

OSR Health: notice of delisting or failure to meet a listing standard

Form 8-K filed Oct 28, 2026 · items 3.01, 7.01

Delisting noticesOSR Health Provides Shareholder Update Following Nasdaq Panel Decision

What the filing says

As previously disclosed, trading in the common stock and warrants of OSR Health, Inc. (the “Company”) on The Nasdaq Stock Market LLC (“Nasdaq”) was suspended effective at the open of trading on August 26, 2026, due to the Company’s non-compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5

Read the filing on SEC EDGAR →

What usually followsAcross 492 8-Ks reporting Item 3.01 (delisting notice or listing-rule failure) in our universe, the stock's median move the next session was 0.0% (typical size ±2.1%, up 46% of the time); over the following 21 sessions, −0.2%. Every item ranked →

What this kind of filing means

Item 3.01 — Notice of delisting or failure to meet a listing standard. A delisting notice starts a compliance window; companies often answer with a reverse split, a plan, or a move to another market.

OSR Health at a glance

Latest quarterQ2 2026
Revenue$316K
Revenue Y/Y-72%
Operating margin-960.8%
IndustrySurgical & Medical Instruments & Apparatus

OSR Health, Q2 2026: revenue $316K (-72% year over year), operating margin -960.8%. The chart follows the revenue to costs, profit and cash.

OSR Health: every quarter, Q/Q and Y/Y, holders and guidance →

Other recent delisting notices

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.